These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 12610513)

  • 1. Analysis of the candidate 8p21 tumour suppressor, BNIP3L, in breast and ovarian cancer.
    Lai J; Flanagan J; Phillips WA; Chenevix-Trench G; Arnold J
    Br J Cancer; 2003 Jan; 88(2):270-6. PubMed ID: 12610513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping of a candidate colorectal cancer tumor-suppressor gene to a 900-kilobase region on the short arm of chromosome 8.
    Flanagan JM; Healey S; Young J; Whitehall V; Trott DA; Newbold RF; Chenevix-Trench G
    Genes Chromosomes Cancer; 2004 Jul; 40(3):247-60. PubMed ID: 15139003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RPS6KA2, a putative tumour suppressor gene at 6q27 in sporadic epithelial ovarian cancer.
    Bignone PA; Lee KY; Liu Y; Emilion G; Finch J; Soosay AE; Charnock FM; Beck S; Dunham I; Mungall AJ; Ganesan TS
    Oncogene; 2007 Feb; 26(5):683-700. PubMed ID: 16878154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequence variants of DLC1 in colorectal and ovarian tumours.
    Wilson PJ; McGlinn E; Marsh A; Evans T; Arnold J; Wright K; Biden K; Young J; Wainwright B; Wicking C; Chenevix-Trench G
    Hum Mutat; 2000; 15(2):156-65. PubMed ID: 10649492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered expression and loss of heterozygosity of the LOT1 gene in ovarian cancer.
    Cvetkovic D; Pisarcik D; Lee C; Hamilton TC; Abdollahi A
    Gynecol Oncol; 2004 Dec; 95(3):449-55. PubMed ID: 15581945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CBFA2T3 (MTG16) is a putative breast tumor suppressor gene from the breast cancer loss of heterozygosity region at 16q24.3.
    Kochetkova M; McKenzie OL; Bais AJ; Martin JM; Secker GA; Seshadri R; Powell JA; Hinze SJ; Gardner AE; Spendlove HE; O'Callaghan NJ; Cleton-Jansen AM; Cornelisse C; Whitmore SA; Crawford J; Kremmidiotis G; Sutherland GR; Callen DF
    Cancer Res; 2002 Aug; 62(16):4599-604. PubMed ID: 12183414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p27/Kip1 mutation found in breast cancer.
    Spirin KS; Simpson JF; Takeuchi S; Kawamata N; Miller CW; Koeffler HP
    Cancer Res; 1996 May; 56(10):2400-4. PubMed ID: 8625318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of p51 alteration in human ovarian cancer.
    Shinozaki H; Okamoto A; Shimizu K; Saito M; Yokota J; Ochiai K
    Int J Oncol; 2001 Mar; 18(3):549-52. PubMed ID: 11179485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of heterozygosity from the short arm of chromosome 8 is associated with invasive behavior in breast cancer.
    Yaremko ML; Kutza C; Lyzak J; Mick R; Recant WM; Westbrook CA
    Genes Chromosomes Cancer; 1996 Jul; 16(3):189-95. PubMed ID: 8814452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detailed genetic and physical mapping of tumor suppressor loci on chromosome 3p in ovarian cancer.
    Fullwood P; Marchini S; Rader JS; Martinez A; Macartney D; Broggini M; Morelli C; Barbanti-Brodano G; Maher ER; Latif F
    Cancer Res; 1999 Sep; 59(18):4662-7. PubMed ID: 10493522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of ING1 expression in sporadic breast cancer.
    Toyama T; Iwase H; Watson P; Muzik H; Saettler E; Magliocco A; DiFrancesco L; Forsyth P; Garkavtsev I; Kobayashi S; Riabowol K
    Oncogene; 1999 Sep; 18(37):5187-93. PubMed ID: 10498868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression and structure of BNIP3L in lung cancer].
    Sun JL; He XS; Yu YH; Chen ZC
    Ai Zheng; 2004 Jan; 23(1):8-14. PubMed ID: 14720367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation analysis of the 8p candidate tumour suppressor genes DBC2 (RHOBTB2) and LZTS1 in bladder cancer.
    Knowles MA; Aveyard JS; Taylor CF; Harnden P; Bass S
    Cancer Lett; 2005 Jul; 225(1):121-30. PubMed ID: 15922864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.
    Feng W; Marquez RT; Lu Z; Liu J; Lu KH; Issa JP; Fishman DM; Yu Y; Bast RC
    Cancer; 2008 Apr; 112(7):1489-502. PubMed ID: 18286529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequence-ready contig for the 1.4-cM ductal carcinoma in situ loss of heterozygosity region on chromosome 8p22-p23.
    Wang JC; Radford DM; Holt MS; Helms C; Goate A; Brandt W; Parik M; Phillips NJ; DeSchryver K; Schuh ME; Fair KL; Ritter JH; Marshall P; Donis-Keller H
    Genomics; 1999 Aug; 60(1):1-11. PubMed ID: 10458905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequent down-regulation and lack of mutation of the KAI1 metastasis suppressor gene in epithelial ovarian carcinoma.
    Liu FS; Dong JT; Chen JT; Hsieh YT; Ho ES; Hung MJ
    Gynecol Oncol; 2000 Jul; 78(1):10-5. PubMed ID: 10873402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The TES gene at 7q31.1 is methylated in tumours and encodes a novel growth-suppressing LIM domain protein.
    Tobias ES; Hurlstone AF; MacKenzie E; McFarlane R; Black DM
    Oncogene; 2001 May; 20(22):2844-53. PubMed ID: 11420696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LAPSER1: a novel candidate tumor suppressor gene from 10q24.3.
    Cabeza-Arvelaiz Y; Thompson TC; Sepulveda JL; Chinault AC
    Oncogene; 2001 Oct; 20(46):6707-17. PubMed ID: 11709705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased expression of the Id3 gene at 1p36.1 in ovarian adenocarcinomas.
    Arnold JM; Mok SC; Purdie D; Chenevix-Trench G
    Br J Cancer; 2001 Feb; 84(3):352-9. PubMed ID: 11161400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation analysis of the THRA1 gene in breast cancer: deletion/fusion of the gene to a novel sequence on 17q in the BT474 cell line.
    Futreal PA; Cochran C; Marks JR; Iglehart JD; Zimmerman W; Barrett JC; Wiseman RW
    Cancer Res; 1994 Apr; 54(7):1791-4. PubMed ID: 7511052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.